Tumor cells evade IFN-γ by downregulating or mutating the molecules involved in the IFN-γ signaling pathway, such as JAK1/2 and STAT, thus blocking the IFN-γ signaling pathway. The gene discussed is JAK1; the disease is neoplasm.